|1.||Barni, Sandro: 1 article (10/2009)|
|2.||Petrelli, Fausto: 1 article (10/2009)|
|3.||Ghilardi, Mara: 1 article (10/2009)|
|4.||Cabiddu, Mary: 1 article (10/2009)|
|5.||Ward, Sean M: 1 article (01/2004)|
|6.||Takayama, Ichiro: 1 article (01/2004)|
|7.||Sanders, Kenton M: 1 article (01/2004)|
|8.||Fujino, Masayuki A: 1 article (01/2004)|
|9.||Daigo, Yataro: 1 article (01/2004)|
10/01/2009 - "Approximately 10 - 15% of breast carcinomas (BCs) are known to be 'triple-negative (TN) receptor' (i.e., not expressing ER or PR and not exhibiting overexpression and/or gene amplification of HER2-neu). "
01/01/2004 - "Expression of another five genes was decreased in W/W(V) mice: BB1 (overexpressed in bladder and breast carcinoma), HTATIP/CPLA2 (HIV-1 TAT interactive protein/cytosolic phospholipase A2), Tenascin-receptor like (Hexabrachion, Cytotactin, Neuronectin, Myotendinous antigen), and two novel transcripts: DRWMS1 and DRWMS2. "
|1.||Phospholipases A2 (Phospholipase A2)